CONCENTRATIONS |
6 Months Ended |
|---|---|
Jun. 30, 2017 | |
| Notes to Financial Statements | |
| NOTE L - CONCENTRATIONS |
Revenue from two licensees constituted approximately 26% and 47% of the Company's revenue for the three months ended June 30, 2017, and 55% and 21% of the Company's revenue for the six months ended June 30, 2017. Revenue from one licensee constituted approximately 50% and 76% for the three and six months ended June 30, 2016 (exclusive of revenue from our professional liability settlement – see Note M), respectively. At June 30, 2017, royalty receivables from three licensees constituted approximately 24%, 29% and 35% of the Company's net royalty receivables. At December 31, 2016, royalty receivables from three licenses constituted approximately 29%, 45% and 11% of the Company's net royalty receivables. |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|